Provided by Tiger Trade Technology Pte. Ltd.

Oxford

34.66
+2.778.69%
Post-market: 34.660.00000.00%19:37 EDT
Volume:1.03M
Turnover:36.18M
Market Cap:515.65M
PE:-103.28
High:37.36
Open:34.93
Low:32.50
Close:31.89
52wk High:61.99
52wk Low:30.57
Shares:14.88M
Float Shares:14.30M
Volume Ratio:2.17
T/O Rate:7.18%
Dividend:2.74
Dividend Rate:7.91%
EPS(TTM):-0.3356
EPS(LYR):5.87
ROE:-4.90%
ROA:1.43%
PB:1.00
PE(LYR):5.90

Loading ...

Corrected-Oxford Industries Outlook Q1 Revenue USD 385-395 Million (Corrects Amount)

THOMSON REUTERS
·
Yesterday

Oxford Industries: in 2026, Co Expects Net Sales in Range of $1.475 Bln to $1.530 Bln

THOMSON REUTERS
·
Yesterday

Oxford Industries Inc FY2026 Shr View $2.24, REV View $1.48 Bln -- Lseg Ibes Data

THOMSON REUTERS
·
Yesterday

U.S. Earnings Preview: After Market Close March 26

Dow Jones
·
Yesterday

Oxford Nanopore Files New 50 Million-Share Block Admission for Incentive Plans

TIPRANKS
·
Mar 26

Press Release: MetaVia Reports Year End 2025 Financial Results and Provides Corporate Update

Dow Jones
·
Mar 26

Oxford Industries Likely To Report Lower Q4 Earnings; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

Benzinga
·
Mar 26

Oxford BioMedica Returns to Profit as U.S. Expansion and Big Pharma Deals Lift Outlook

TIPRANKS
·
Mar 26

Oxford Nanopore price target lowered to 225 GBp from 300 GBp at RBC Capital

TIPRANKS
·
Mar 25

Oxford Biomedica resumed with a Buy at Jefferies

TIPRANKS
·
Mar 23

U.K. Inflation Could Reach 4% Later in 2026, Oxford Economics -- Market Talk

Dow Jones
·
Mar 20

Oxford Industries Is Maintained at Neutral by UBS

Dow Jones
·
Mar 20

UBS Adjusts Price Target on Oxford Industries to $35 From $36, Maintains Neutral Rating

MT Newswires Live
·
Mar 19

Oxford Industries price target lowered to $35 from $36 at UBS

TIPRANKS
·
Mar 19

Oxford Metrics Buys Back Shares, Trims Voting Capital

TIPRANKS
·
Mar 19

Oxford Metrics Buys Back 80,000 Shares, Tightening Share Base

TIPRANKS
·
Mar 18

Mdxhealth Highlights Data from Oxford’s ProMPT Study Demonstrating the Genomic Prostate Score GPS Test Predicts Adverse Outcomes Across Multiple Treatment Settings at EAU 2026

GlobeNewswire
·
Mar 17

Oxford Metrics Cuts Share Count with 100,000-Share Buyback

TIPRANKS
·
Mar 11

Oxford Lane sees February NAV per share $11.59-$11.89

TIPRANKS
·
Mar 11

Oxford to Release Fourth Quarter Fiscal 2025 Results on March 26, 2026

GlobeNewswire
·
Mar 10